Adaptive Biotechnologies (ADPT)
(Delayed Data from NSDQ)
$2.75 USD
+0.15 (5.77%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $2.74 -0.01 (-0.36%) 5:04 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/7/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.30 |
Last EPS Surprise | 6.25% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.31 |
Next Year | -1.06 |
EPS (TTM) | -1.38 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 42.20M | 42.57M | 177.19M | 228.60M |
# of Estimates | 1 | 4 | 5 | 5 |
High Estimate | 42.20M | 43.84M | 185.10M | 256.40M |
Low Estimate | 42.20M | 41.70M | 172.70M | 207.50M |
Year ago Sales | 37.65M | 48.93M | 170.28M | 177.19M |
Year over Year Growth Est. | 12.08% | -13.00% | 4.06% | 29.01% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.33 | -1.31 | -1.06 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.33 | -0.33 | -1.29 | -1.29 |
High Estimate | -0.33 | -0.31 | -1.29 | -0.65 |
Low Estimate | -0.37 | -0.34 | -1.37 | -1.29 |
Year ago EPS | -0.40 | -0.33 | -1.38 | -1.31 |
Year over Year Growth Est. | 12.50% | 0.00% | 5.07% | 19.27% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.33 | -1.31 | -1.06 |
7 Days Ago | -0.35 | -0.33 | -1.31 | -1.06 |
30 Days Ago | -0.35 | -0.33 | -1.31 | -1.06 |
60 Days Ago | -0.35 | -0.33 | -1.27 | -1.06 |
90 Days Ago | -0.32 | -0.30 | -1.10 | -0.77 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.33 | -1.31 | -1.06 |
Zacks Consensus Estimate | -0.35 | -0.33 | -1.31 | -1.06 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.30 | -0.35 | -0.33 | -0.40 | NA |
Estimate | -0.32 | -0.32 | -0.33 | -0.34 | NA |
Difference | 0.02 | -0.03 | 0.00 | -0.06 | -0.02 |
Surprise | 6.25% | -9.38% | 0.00% | -17.65% | -5.20% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more